Prevalence of inhaled corticosteroid use among patients with chronic obstructive pulmonary disease: A survey

Annals of Pharmacotherapy

Volumn 31, Issue 2, 1997, Pages 160-164

  Jackevicius, Cynthia A ^a,b,d   Chapman, Kenneth R ^a,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; HOSPITAL PATIENT; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

EID: 0031032204     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100204     Document Type: Article

References (24)

1. Barnes PJ. A new approach to the treatment of asthma. N Engl J Med 1989;321:1517-27.
2. Jenkins CK, Woolcock AJ. Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study. Thorax 1988;43:378-84.
3. Hatoum HT, Schumock GT, Kendzierski DL. Meta-analysis of controlled trials of drug therapy in mild chronic asthma: the role of inhaled corticosteroids. Ann Pharmacother 1994;28:1285-9.
4. Ferguson GT, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med 1993;328:1017-22.
5. Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysis. Ann Intern Med 1991;114:216-23.
6. Postma DS, Steenhuis EJ, Van der Weele LT, Sluiter HJ. Severe chronic airflow obstruction: can corticosteroids slow down progression? Eur J Respir Dis 1985;67:56-64.
7. Postma DS, Peters I, Steenhuis EJ, Sluiter HJ. Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction? Eur Respir J 1988;1:22-6.
8. Murata GH, Gorby MS, Chick TW, Halperin AK. Intravenous and oral corticosteroids for the prevention of relapse after treatment of decompensated COPD: effect on patients with a history of multiple relapses. Chest 1990;98:845-9.
9. Weir DC, Gove RI, Robertson AS, Burge PS. Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate. Thorax 1990;45:112-7.
10. Canadian Thoracic Society Workshop Group. Guidelines for the assessment and management of chronic obstructive pulmonary disease. Can Med Assoc J 1992;147:420-8.
11. Shim CS, Williams MH. Aerosol beclomethasone in patients with steroid-responsive chronic obstructive pulmonary disease. Am J Med 1985;78:655-8.
12. Engel T, Heinig JH, Madson M, Weeke ER. A trial of inhaled budesonide on airway responsiveness in smokers with chronic bronchitis. Eur Respir J 1989;2:935-9.
13. Auffarth B, Postma DS, de Monchy JGR, van der Mark ThW, Boorsma M, Koeter GH, et al. Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease. Thorax 1991;46:372-7.
14. Thompson AB, Mueller MB, Heires AJ, Bohling TL, Daughton D, Yancey SW, et al. Aerosolized beclomethasone in chronic bronchitis: improved pulmonary function and diminished airway inflammation. Am Rev Respir Dis 1992;146:389-95.
15. Kerstjens HAM, Brand PLP, Hughes MD, Robinson NJ, Postma DS, Sluiter HI, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 1992;327:1413-9.
16. Kesten S, Chapman KR. Physician perceptions and management of COPD. Chest 1993;104:254-8.
17. Weiner P, Weiner M, Azgad Y, Zamir D. Inhaled budesonide therapy for patients with stable COPD. Chest 1995;108:1568-71.
18. Harding SM, Freedman S. A comparison of oral and inhaled steroids in patients with chronic airways obstruction: features determining response. Thorax 1978;33:214-8.
19. Eliasson O, Hoffman J, Trueb D, Frederick D, McCormick JR. Corticosteroids in COPD: a clinical trial and reassessment of the literature. Chest 1986;89:484-90.
20. Kesten S, Rebuck AS, Chapman KR. Trends in asthma and chronic obstructive pulmonary disease therapy in Canada, 1985 to 1990. J Allergy Clin Immunol 1993;92:499-506.
21. Tinkleman DG, Vanderpool GE, Carroll MS, Page G, Spangler DL. Compliance differences following administration of theophylline at six and twelve hour intervals. Ann Allergy 1980;44:283-6.
22. Bittar N. Maintaining long-term control of blood pressure: the role of improved compliance. Clin Cardiol 1995;18(6 suppl 3):III 12-6.
23. Cramer J, Vachon L, Desforges C, Sussman MM. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia 1995;36:1111-7.
24. Hanania NA. Adverse effects of inhaled corticosteroids. Am J Med 1995;98:196-208.